1. Home
  2. NLY vs VTRS Comparison

NLY vs VTRS Comparison

Compare NLY & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLY
  • VTRS
  • Stock Information
  • Founded
  • NLY 1996
  • VTRS 1961
  • Country
  • NLY United States
  • VTRS United States
  • Employees
  • NLY N/A
  • VTRS N/A
  • Industry
  • NLY Real Estate Investment Trusts
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • NLY Real Estate
  • VTRS Health Care
  • Exchange
  • NLY Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • NLY 11.6B
  • VTRS 10.6B
  • IPO Year
  • NLY 1997
  • VTRS N/A
  • Fundamental
  • Price
  • NLY $19.52
  • VTRS $9.33
  • Analyst Decision
  • NLY Buy
  • VTRS Hold
  • Analyst Count
  • NLY 10
  • VTRS 5
  • Target Price
  • NLY $21.00
  • VTRS $10.40
  • AVG Volume (30 Days)
  • NLY 7.8M
  • VTRS 11.7M
  • Earning Date
  • NLY 07-23-2025
  • VTRS 08-07-2025
  • Dividend Yield
  • NLY 14.37%
  • VTRS 5.15%
  • EPS Growth
  • NLY N/A
  • VTRS N/A
  • EPS
  • NLY 0.93
  • VTRS N/A
  • Revenue
  • NLY $956,137,000.00
  • VTRS $14,330,200,000.00
  • Revenue This Year
  • NLY $323.77
  • VTRS N/A
  • Revenue Next Year
  • NLY $1.70
  • VTRS $1.85
  • P/E Ratio
  • NLY $20.85
  • VTRS N/A
  • Revenue Growth
  • NLY N/A
  • VTRS N/A
  • 52 Week Low
  • NLY $16.60
  • VTRS $6.85
  • 52 Week High
  • NLY $22.11
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • NLY 55.56
  • VTRS 62.08
  • Support Level
  • NLY $18.64
  • VTRS $8.88
  • Resistance Level
  • NLY $19.58
  • VTRS $9.40
  • Average True Range (ATR)
  • NLY 0.30
  • VTRS 0.22
  • MACD
  • NLY 0.02
  • VTRS 0.03
  • Stochastic Oscillator
  • NLY 90.43
  • VTRS 89.19

About NLY Annaly Capital Management Inc.

Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are; the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: